FR
ETHZilla Corporation (FRMM)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$3.56
+1.86%
Mkt Cap $55.71M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
Implied Upside
+209.0%
Consensus $11.00 vs current $3.56